Speakers of the Benelux Private Equity Conference 2015
To enquire about your potential speaking opportunities at the upcoming Benelux Private Equity Conference 2017, please contact us at firstname.lastname@example.org.
Opening of The Conference
Tjarda Molenaar is managing director of the Dutch Private Equity & Venture Capital Association (NVP), that represents the interests of the sector. Since 2003, Tjarda has been a member of the General Council of The Confederation of Netherlands Industry and Employers (known as VNO-NCW). Since 2007, she has been a member of the Advisory Committee Seed Capital of the Ministry of Economic Affairs. In 2011, Tjarda was a member of the Expert Group on Finance, advising the Ministry of Economic Affairs (Commissie De Swaan). In 2013, Tjarda joined the Board of the Nyenrode Foundation, owner of Nyenrode Business Universiteit and Nyenrode estate. She also chairs the Supervisory Board of a regional childcare organisation. Before, she was an investment consultant with Gilde Investment Management and a management consultant with A.T. Kearney. Tjarda studied econometrics at the University of Amsterdam.
Marc Zwaaneveld is CEO of Van Gansewinkel Groep since January 2015. He joined Van Gansewinkel in 2014 as COO and brings a broad experience in the Waste Management and Recycling sector. Prior to Van Gansewinkel he was Vice-Chairman and CFO at SITA Benelux & Germany (2005-2011), partner at consultancy firm Accenture and held various positions at DAF Trucks.
Chief Business Operations
Alex Brabers joined Gimv in 1990, after working for one of the predecessors of Belfius Bank. Alex developed the international venture capital activity of Gimv, by investing in new innovative companies, followed by active support of the management team and eventually exiting either through IPO or trade sale. He built the VC team of Gimv and coached them in developing its place in the European VC ecosystem. Since 2012, Alex is responsible for all investment activity of Gimv, overseeing the 4 investment platforms. He is a board member of various listed and non-listed companies, including Inside Secure (F), Nomadesk (B), OTN Systems (B), Oree (Isr) and Punch Powertrain (B). Before that, he was a member of the board of directors of Telenet (B), Mobistar (B), Emme (F), Barco (B), Barconet (B), Option (B), Virtensys (UK) and Telos (Ca). Alex is involved in policy issues for the European VC and PE industry as board member of EVCA and as previous chairman of the Venture Capital Platform of EVCA. Alex Brabers holds a Master degree in Economics KU Leuven (Belgium).
The Riverside Company
Since 2006, Mr. Langer has been a Partner at global private equity firm The Riverside Company. Having previously built the firm’s pan-European origination team, Mr. Langer now leads the firm’s investment and portfolio management activities in the Benelux countries and France. Prior to Riverside, Mr. Langer was Managing Partner of an independent corporate finance firm in Brussels, advising on acquisitions and divestitures across Europe. Before that, he spent five years with GE Capital, in operating management and investment roles. Mr. Langer started his career with Danske Bank in Copenhagen. He holds a Masters in Management from EAP – European School of Management (now ESCP Europe) and a Bachelor’s degree from Copenhagen Business School. He speaks English, French, Danish, German, Portuguese and basic Dutch. For the year until June 2012, Mr. Langer served as Chairman of the EVCA (European Private Equity and Venture Capital Association).
Maarten is the global head of the Fund of Funds program as well as a member of the global operating committee of AlpInvest Partners. AlpInvest is the Private Equity Fund-of-Funds Arm of Carlyle Solutions Group and a leading private equity asset manager with €37 billion (US$47 billion) of assets under management as of September 30, 2014. AlpInvest invests worldwide across the primary fund, secondaries and direct investment channels, covering the entire private equity spectrum including mezzanine.
Jesse De Klerk
Director, RobecoSAM Private Equity
Jesse de Klerk is the head of the global primary fund investment practice for RobecoSAM Private Equity, and is a member of the Allocation and Investment Committees. Previously he was employed by KPMG, Andersen and Deutsche Bank. Mr. De Klerk holds an M.Sc. cum laude in Financial Econometrics from the Erasmus University in Rotterdam, is a CFA-charter holder, and a CAIA-charter holder. Since joining RobecoSAM Private Equity 12 years ago he has had a strong focus on the European market. In addition, he has been closely involved in building out the firm’s sustainability activities in the private equity asset class, which include thematic investment strategies and an award winning ESG monitoring and engagement program.
Alexandrine’s practice focuses on advising private equity sponsors on their investments, corporate finance, syndicated financings and fund formation, including leveraged financing and restructurings. She acts for a wide range of investment houses in the private equity, real estate and leveraged finance sectors. Recommended in Legal 500 (Luxembourg) which states that she is "a standout lawyer with an exceptional ability to grasp complex projects and respond to clients’ requirements and needs".
Pieter de Jong
Partner & Managing Director
Pieter joined 3i in 2004 and is Partner, Managing Director of 3i Benelux, based in Amsterdam. He was a key member of the deal team involved in Refresco Gerber, Action, TouchTunes, Basic-Fit and Weener Plastic Packaging Group, and currently sits on the Boards of Refresco-Gerber, Basic-Fit and Weener. He has more than 25 years experience in corporate finance, management and operations. Pieter started his career at Stork in the US, before joining Van Den Boom Groep, a corporate finance consulting firm in Benelux, where he became partner responsible for M&A. After selling the company to NIBC, Pieter headed the M&A department. Pieter has an MBA degree from Georgia State University (USA) and a BBA degree from Nijenrode University (Netherlands).
Hans van Swaay
Partner & Founder
Lyrique Private Equity
Hans van Swaay has been active for more than twenty years in private equity as co-founder of Lyrique, as Head of Private Equity at Pictet & Cie, as Managing Director of UBS Capital, as Managing Director of Merifin and as partner of Lowe Finance. Lyrique invests in private equity for family offices and for private and institutional asset managers. Lyrique makes fund investments in the world’s best private equity and venture capital funds. It also co-invests with these funds. In specific situations Lyrique makes direct investments in and around Switzerland with a focus on succession situations and re-structuring. Hans has made fund investments worldwide and direct investments in Switzerland, Germany, France, the United Kingdom and in the Netherlands. He is on numerous boards, restructured companies and ran companies as CEO when necessary. Hans van Swaay holds an MBA with honors from IMD (Switzerland), an MSc. in engineering geology from Leeds University (UK) and a BSc. in geology from Leiden University (the Netherlands).
Frédéric Collard holds an MBA and is a certified French Financial Analyst. He held several positions as financial analyst and fund manager until 1990 when he joined the private equity team of Dominique Senequier. He participated to the launch of ARDIAN (at that time AXA Private Equity) in 1996 and was an active member of its LBO Mid Cap team until 2010 involved notably on transactions like Continental Sweets (Franco-Dutch sugar confectionary), Grand Moulins de Paris (European flour and bakery producer and retailer), Tokheim (World supplier of products and services for petrol station). Since then, he invests AXA Capital, a fund of €328m taking minority stakes in listed companies. This fund launched with the Chinese conglomerate Fosun, the 1rst tender offer on Club Méditerranée in 2013. He is also active on the Central and Eastern Europe fund and Co-investment funds.
Richard Damming covers Adveq's investment activity for the European investment program. Before joining Adveq in 2011, Richard worked at Capvent AG, a Zurich based private equity fund of funds firm. From 2006 to 2009, Richard was an Associate in the Corporate Finance team of PricewaterhouseCoopers in Zurich. Richard was also a controller and corporate M&A Analyst for ABB Ltd. from 2004 to 2005. Richard holds a Master’s degree in Business Administration with a specialization in Corporate Finance from Bocconi University Milan, Italy.
Robin Muerer is a Principal in the Consumer team, where he focusses on the DACH and Benelux markets. He was involved in the recent acquisition of wehkamp by Apax Funds. Robin joined Apax in 2007 in the Munich office and since 2013 he has been based in London. Robin joined from the Boston Consulting Group, where he worked in the Retail and Healthcare groups. He holds an MSc in Physics from the ETH Zürich and an MBA from the London Business School.
MODERATOR: Jérôme Wittamer
Jérôme Wittamer is Managing Partner of Expon Capital, a Luxembourg-based VC firm with a focus on Exponential Technologies & Markets from Europe, the US and Israel. Prior to this, he ran Genii Capital’s Investment Management business and before that, served as Group CFO at DCL Group, where he co-founded several companies and held various executive and board positions. Earlier in his career, Jérôme served for seven years as senior member of the management team at BIP Investment Partners S.A, an early stage to blue chips investment firm. While at BIP Investment Partners, he co-founded VOXmobile, a mobile telephone operator, where he served as Board Member and CFO. The company was sold to Mobistar (Orange). Jérôme also successfully invested in media and communication technology companies such as EVS, OPTION and Evertz. Over the years he has been active in multiple nonprofit organisations supporting education and entrepreneurship (JEL), Luxembourg’s internet connectivity (LUCIX) and Luxembourg’s Venture Capital & Private Equity ecosystem (LPEA) which is he currently Presiding. Jérôme Wittamer graduated Cum Laude from Université Catholique de Louvain, where he obtained a Master of Law. He received his MBA from the RSM Erasmus Graduate School of Business. He is fluent in French and English.
Since 2011, Nicolas leads the Corporate Finance practice of GGM Capital, an investment banking boutiques with offices in Luxembourg, Spain and UK. Prior to GGM Capital, Nicolas worked several years within the Luxembourg practice of KPMG where he was involved in a large number of international M&A transactions. Before KPMG Luxembourg, Nicolas had gained prior experience in the automotive industry in Paris, at Volkswagen or PSA Peugeot Citroen. Nicolas is also a board member of LPEA, the Luxembourg association promoting the domestic place for the Private Equity and Venture Capital industry.
SL Capital Partners
Richard is based in the Edinburgh office and joined SL Capital in 2007. He is responsible for primary fund investment, secondary investments and co-investments. Richard has a particular focus on the European turnaround market, as well as the Italian and Benelux buyout markets. He is also involved in the management of SL Capital’s listed vehicle, SLEPET. Prior to joining SL Capital Richard worked for the corporate finance team of Noble Group as an advisor on M&A transactions in the financial and oil & gas sectors. He has an MA (joint hons) in Management and Psychology from the University of St Andrews and the Corporate Finance Diploma from ICAEW.
CEO & Managing Partner
Joost Bergsma founded Glennmont Partners in 2013 completing a spin out of BNP Paribas Clean Energy Partners which had been established since 2008. At the end of 2010, Glennmont Partners finalised its fund raising at Euro435m for its first clean energy fund. In August 2014, Glennmont announced the final close of its second clean energy fund, having raised Euro500m, Euro50m more than its target. Joost has been active in utility banking and fund management for more than twenty years and has specialised in the power sector and clean energy. In this time, he has devised and implemented asset and exit strategies, raising in excess of EUR 10bn of sales proceeds for energy clients. He is actively involved in originating new deals through the fund’s development partners, and regularly speaks at conferences and industry events. As founding partner and CEO of Glennmont Partners, Joost has been involved in negotiations of some of the fund’s key wind and solar transactions. Previously, Joost worked at SG Warburg & Co., ABN AMRO and BNP Paribas. He has read law at Leiden University (the Netherlands) and has an MBA from INSEAD (France).
Adams Street Partners
As a Partner and Head of Business Development for Europe, the Middle East and Africa, John’s responsibilities focus on the development of institutional client and consultant relationships and working with other members of the client service team to serve the needs of Adams Street Partners’ clients. Before joining our organization in 2011, John was with Credit Suisse Asset Management (CSAM) where he was a Managing Director and Global Head of Single Strategy Hedge Funds. In his initial role with CSAM, John was Head of European Institutional Distribution with responsibility for relationship management and distribution activity for all asset management institutional clients in Europe, the Middle East and Africa. Prior to CSAM, John joined Lehman Brothers in London where he served as the President of Lehman Brothers Alternative Investment Management. In this role he built and directed a global distribution team for hedge fund, fund of fund and commodity-related asset management products. Prior roles include senior distribution positions with UBS O’Connor in Hong Kong, Tokyo and London, and positions with Merrill Lynch in Singapore, Tokyo and London with the Foreign Exchange and Fixed Income Sales area covering global hedge fund and sovereign accounts.
Partner & Managing Director
Martin Dunnett has worked in the financial services industry for the last 31 years, 23 of which, he has focused on Private Equity. Martin is a Partner based in the London office of Warburg Pincus and covers Europe. Prior to Warburg Pincus he was Global Head of Private Equity at UBS Wealth Management for 9 years and built the PE business from zero to $9bn of AUM globally. He was a Director at Schroder Ventures (now Permira) and then Head of European Private Equity for Ernst & Young working with many of the top European PE firms. Prior to this he worked for 7 years for Esso Petroleum in various sales, marketing and strategic planning roles.
MODERATOR: Marcel van de Vorst
Marcel van de Vorst is a partner of the international law firm Jones Day, he serves as a member of the Supervisory Board of Value8 N.V. (listed on Euronext Amsterdam) and is an angel investor. As a corporate lawyer he has a broad transactional and corporate advisory practice focused on technology, life sciences, and growth businesses at all stages of development. He has represented globally operating companies, venture capital and private equity funds, investment banks, and other institutions that are active in the sector. Marcel is regarded as one of the leading VC/PE lawyers for technology companies in the Netherlands and has a strong track record in cross-border M&A transactions regarding technology companies. Understanding the differences in culture and legal concepts in international transactions, he is able to bridge and translate these to make a deal happen. Marcel is repeatedly recommended in the leading legal directories for his in-depth understanding of private equity: Recognized in the field of private equity by Chambers Europe 2013 and 2014 Recommended firm for The Netherlands private equity in The Legal 500 EMEA 2014 "An absolute star who is in a class of his own," The Legal 500 EMEA 2011
Coenraad de Vries
Coenraad de Vries is an Early-stage investor in Clean Tech & Sustainability Solutions. He is Co-Founder of Start Green Venture Capital (the largest specialized clean tech fund in the Netherlands) and Co-founder of OnePlanetcrowd, a crowdfunding platform that finances sustainable innovation by new crowd finance instruments. Previously, Coenraad worked for Fortis Venturing, the innovation-hub and incubator of Fortis Group. In this function he designed and built several new financial products and strategic ventures for Fortis Group.
Don Ginsel is an Amsterdam based Entrepreneur and Investor in early stage startups and an expert in banking, M&A, investment management and strategy consulting. He is passionate about mentoring startup teams and helping them shape their business model, get connected to clients and get funded. Don founded several companies such as Holland FinTech, a membership organization that supports FinTech startups and the broader financial innovation ecosystem, Capital Waters, providing free standardised deal documents for investor and startups, and Principe Management, an early stage investment advisory firm. Next to this he is also active as a mentor and coach through several accelerators and incubators such as Rockstart and Startup Weekend. Previously he has worked for ABN AMRO and Deutsche Bank and for investment firm ICOS Capital. Don is involved in several initiatives to help startups get funded and grow. He is a regular guest on the radio in BNR Zaken doen met… to discuss startups.
Harrold van Barlingen
Prior to founding Thuja Capital in 2006, Harrold headed the life sciences effort of AlpInvest Partners managing a portfolio of over 30 companies. Harrold joined AlpInvest Partners in 2001, from the Boston Consulting Group (BCG), where he worked as a consultant in management and strategy. Before BCG, he was acting head of the continental activities of the Lewin Group (a Quintiles subsidiary), an internationally active firm specialized in the field of health economics. Harrold holds a M.Sc. degree in Medical Biology and a Ph.D. in Medicine, both from Utrecht University.
Frank Maene has been working with software startups for the past 25 years, both as investor, coach and board member, and as an operational executive. He has been a Managing Partner at Hummingbird Ventures and Big Bang Ventures. Notable transactions include exits to Symantec and SUN and co-investments with Amazon and Intel. Currently focusing on startups with HQ’s in the Benelux, he has operational experience in Silicon Valley and Turkey/Middle East.
General Partner & CEO
Nityen has been active in venture capital for over 13 years and in technology industry for about 20 years. He has served as an executive and Director on the board for several start-ups in California, Israel, India and Europe. At Icos Capital, Nityen is active with water, recycling and energy efficiency process technologies. Prior to launching Icos Capital, Nityen acquired important expertise in the renewable energy sector and structured finance at Deloitte. Nityen has an MBA from Rotterdam School of Management, Erasmus University (the Netherlands), a Master in Information Science from Claremont Graduate University (U.S.), and a Bachelor in Computer Science from Michigan Tech University (U.S.).
Joost Holleman joined Prime Ventures as Partner in 2009. Before joining Prime, Joost was with AlpInvest Partners in Amsterdam, one of the leading independent investors in private equity funds in the world (35 billion euro under management). As of 2001 he has led a large number of fund investments on behalf of AlpInvest in buy-out, mezzanine and particularly in venture capital. He was a member of numerous advisory boards in Europe and Israel. Before his time at AlpInvest Joost was a senior consultant at PricewaterhouseCoopers in the area of strategy and organizational design (1997 – 2001). Preceding that period he was research fellow at Leiden University.
MODERATOR: Luca Gallinelli
Senior Vice President & PE Leader
As Private Equity Leader of SGG Luxembourg, Luca Gallinelli directs both the commercial and operational activities of the organisation’s Private Equity client department. Mr. Gallinelli specialises in venture capital transactions, as well as securitisations, structured finance and capital markets. He also oversees the accounting, company secretarial services and tax compliance aspects of the division. His expertise in financial engineering, teamed with his extensive experience in business development of the Private Equity market reinforces his contribution to SGG’s client portfolio and the overall performance of the firm’s Private Equity department. Mr. Gallinelli has led a truly international career. He is a qualified chartered accountant in Italy and Luxembourg and has also held senior management positions in the USA, Italy and at present, Luxembourg. In addition to regularly speaking at conferences around the globe, Luca also publishes articles on Private Equity topics.
Helen Steers joined Pantheon in 2004 and has 24 years of private equity experience. Helen leads Pantheon’s European primary investment activity and chairs the European Investment Committee. Helen is also a member of the International Investment Committee and the Co-investment Committee. Helen joined Pantheon in 2004 from Russell Investments in Paris, where she was Managing Director with overall responsibility for private equity in Europe. Prior to joining Russell in 1999, Helen spent five years as Director, European Private Equity with the Caisse de dépôt et placement du Québec. From 1989 to 1994, Helen was a senior investment manager at the Business Development Bank of Canada in Montréal. Helen received a BA and an MA in Engineering from the University of Cambridge and an MBA from the University of Western Ontario in Canada. Helen, who is bilingual in English and French, is based in London.
Barend Bloemarts is a Vice President in the Funds Investment team of AlpInvest Partners, where he is responsible for sourcing, evaluating, and executing fund opportunities in Europe. He joined AlpInvest Partners in 2006 and is based in Amsterdam. Barend has successfully completed the CFA program and received an MSc, cum laude, in Economics from the University of Groningen, the Netherlands. AlpInvest is the Private Equity Fund-of-Funds Arm of Carlyle Solutions Group and a leading private equity asset manager with over €42 billion of assets under management. AlpInvest invests worldwide across the primary fund, secondaries and direct investment channels, covering the entire private equity spectrum including mezzanine. AlpInvest operates from offices in Amsterdam, Hong Kong, and New York with a team of more than 150 professionals, of which more than 70 are investment professionals.
LGT Capital Partners
Tycho Sneyers (Belgian) is a managing partner at LGT CP Ltd. Prior to joining LGT CP in 2001, Mr. Sneyers co-founded Altgate Capital, a research and advisory firm dedicated to alternative investments. Before that, he worked at Goldman Sachs in the Equities and Investment Banking divisions in London and New York. Prior to that, Mr. Sneyers worked at Andersen Consulting (now Accenture) in the Financial Services Strategy group, where he focused on international banking and insurance projects in Brussels, Luxembourg and Paris. Mr. Sneyers holds an MBA from Harvard Business School and an MA in Economics from the University of Antwerp. He is fluent in English, Dutch and French, and conversant in German and Spanish.
Munich Private Equity Partners
Nathalie joined Munich Private Equity Partners (“MPEP“) in 2008 and leads the firm´s European investment efforts. Nathalie is a member of the investment committee and serves on several advisory boards of MPEP portfolio funds. Prior to 2008, she worked in consulting for more than 3 years. Nathalie has a degree in Political Science and Economics from the Friedrich Alexander University in Nuremberg. MPEP is the investment adviser of RWB Group, a German headquartered financial services company with $2.3 billion of assets under management. RWB was founded in 1999 and has grown to be one of Germanys leading independent investors in private equity.
Access Capital Partners
Alexandre Delos joined Access in October 2000. He has 15 years of experience in private equity. He joined Access Capital Partners in October 2000 and progressed from Analyst, Associate to Investment Director. From January 2007 to June 2008, Alexandre was Vice-President at LGT Capital Partners. He returned to Access in September 2008 as Partner. He holds a degree from ISEG business school in Lille and is a French national.
In-depth Outlook – Life Science
MODERATOR: Nathalie Moll
After graduating with Honours in Biochemistry and Biotechnology from St Andrews University, Scotland, and a stage at the European Commission, Nathalie has spent nearly 20 years working for the biotech industry at EU and national level. Nathalie started working in the biotechnology and food policy area for the European Crop Protection Association in Brussels and then moved to Rome to work for Dompé Farmaceutici S.p.A and the Italian National Biotech Association, Assobiotec dealing with the implementation of European biotech legislation at National level. Within EuropaBio, Nathalie has held the posts of External Relations Manager, Director for Strategic Policy, Director for Healthcare Biotech, Director for Agricultural Biotech sector and Secretary General since 2010. In the course of her career, Nathalie has focused on improving awareness of the importance and benefits of biotechnology for society and has worked, together with the industry, regulators and stakeholders, towards developing a more supportive legislative framework and operating environment for the industry and related sectors. In 2013, Nathalie won the Technovisionaries Women Innovation Award organised by Women & Technologies® while in 2009, Nathalie and the Green Biotech Team at EuropaBio were presented with the Leadership and Excellence in Advancing Ag-Biotech and Food Issues Award.
Pieter van der Meer
Pieter is founder and managing partner of Gilde Healthcare. He is (co-)responsible for general management, investment selection and fundraising of the healthcare technology and services funds. Pieter joined Gilde in 1998 following a position as management consultant with KPMG. He has a MSc in bio-organic chemistry. Gilde Healthcare is a European fund manager specialized in fast growing private healthcare companies. Since 2001 Gilde Healthcare raised dedicated funds across two business lines: Healthcare Technologies and Healthcare Services. The Gilde Healthcare Technology funds invest growth capital in businesses active in digital health, medical technologies and therapeutics, both in Europe and North-America. The Gilde Healthcare Services funds participate in lower mid-market service providers in the Benelux and Germany. Gilde is preparing the launch of Gilde Healthcare IV, a €250M Healthcare Technology fund.
Partner Health-tech Investment Practice
Capricorn Venture Partne
Frank Bulens joined Capricorn Venture Partners in 2009 and is a member of its management committee and board of directors. Frank is actively involved with various health technologies such as diagnostics, therapeutics and medical devices as well as digital health-tech for the various Capricorn funds that are investing in these areas, namely the Capricorn Health-tech Fund, the Capricorn ICT Fund and the Quest for Growth Fund. Previously, he was a member of the life science venture capital team at Gimv (Antwerp, Belgium) for a period of 11 years. Before joining Gimv he worked one year at the IWT, a research fund organization in Brussels, as a senior scientific advisor. Prior to IWT Frank worked 10 years at the Faculty of Medicine, University of Leuven as a PhD and postdoctoral researcher. Before that Frank worked two years in the food industry. Frank is trained as an industrial engineer in chemistry/biochemistry and obtained a Master Degree as well as a PhD in Medical Sciences at the University of Leuven, Belgium. Throughout his 15+ years of making active venture capital investments Frank collected a vast experience in building early stage tech companies towards a successful exit through a trade sale or an IPO. His past board memberships involved a number of companies such as Ablynx in Belgium, Arrow Therapeutics and Prosonix in the UK, Innate Pharma and Fovea Pharmaceuticals in France as well as Aclara Biosciences and X-Ceptor in the US. Current active board memberships include Sequana Medical (Switzerland), Trinean (Belgium) and TROD Medical (Belgium).
Vice President & Managing Director
MS Ventures (Merck Serono)
Roel Bulthuis is the Managing Director of MS Ventures, the strategic venture capital fund of Merck Serono, which he established in 2009. MS Ventures has a strategic mandate and invests in companies that develop products and/ or technologies that could benefit patients in therapeutic areas relevant to Merck Serono. MS Ventures has a total of € 140 million under management for strategic investments, investments through its Israel BioIncubator and for spin-offs from the Merck Serono organization through the Merck Serono Entrepreneur Partnership Program. Previously, Roel was a Director in the Biotech Investment Banking Team at Fortis Bank, based out of Amsterdam and New York. Before that, he worked at Devgen in Ghent, Belgium. Roel is currently the Chairman of Asceneuron and a member of the Board at Calypso Biotech, Canbex Therapeutics, Metabomed, Padlock Therapeutics and RuiYi. Roel is an observer on the Board of f-Star and was previously a Director at Prexton Therapeutics, Rana Therapeutics and Vaximm.
Francesco De Rubertis
Francesco is a Partner and co-founder of the firm's life sciences practice. He joined Index in 1998 and has overseen all of the life sciences investment of the firm. Present and past Index portfolio companies include: Minerva (NERV), Versartis (VSAR), Egalet (EGLT), Genmab A/S (Coph: GEN.CO), CellZome Inc. (sold to GlaxoSmithKline), Molecular Partners A/G, Aegerion Inc. (Nasdaq: AEGR), Addex Pharmaceuticals SA (Swx: ADXN), PanGenetics B/V (sold to Abbott Pharmaceuticals), Micromet Inc. (sold to Amgen), Bioxell SpA (sold to Cosmo Pharmaceuticals) and Parallele Inc. (sold to Affymetrix). Francesco has served on most of these boards. Prior to joining Index, Francesco was involved in post-doctoral research in genetics at the Whitehead Institute, Massachusetts Institute of Technology (MIT). He is also the author of several publications in international scientific journals. Francesco has a BA in Genetics and Microbiology from the University of Pavia and a PhD in Molecular Biology from the University of Geneva. He is a CFA charter holder, and is a member of the Strategic Advisory Board of the University of Geneva. Francesco was named by BioWorld as one of 28 "movers and shakers" predicted to shape the biotechnology industry over the next two decades.
Dr. Rainer Strohmenger
With over 20 investments in start-up companies, Dr. Rainer Strohmenger is one of Europe’s most experienced venture capitalists in life sciences. Joining Wellington Partners (www.wellington-partners.com) in 1997, he became a Partner in December 2000. His eighteen years of investment activity have involved financing of some of the most successful European biotech, medtech, and diagnostics companies as well as 6 IPOs and 7 successful trade sales. In the late 1990s Dr. Strohmenger co-managed Wellington’s investment in Swiss biotech player Actelion (SWX: ATLN; www.actelion.com), today a listed company with a market capitalization of more than € 14 billion. He also was responsible for the investments in 4SC (Deutsche Boerse:VSC; ISIN DE000A14KL72; www.4sc.com); Definiens (acquired by Medimmune), Grandis (acquired by Novartis), NoemaLife (Borsa Italiana: NOE; www.noemalife.com), Wavelight (acquired by Alcon), 20/10 Perfect Vision (acquired by Bausch & Lomb), immatics (www.immatics.com), mtm laboratories (acquired by Roche) as well as Oxford Immunotec (NASDAQ: OXFD; www.oxfordimmunotec.com), and represents Wellington on the boards of the portfolio companies Genticel (NYSE Euronext: GTCL; www.genticel.com), Implanet (NYSE Euronext: IMPL; www.implanet.com), invendo medical (www.invendo-medical.com), NEUWAY Pharma (www.neuway-pharma.com) and Quanta Fluid Solutions (www.quantafs.com). Prior to joining Wellington Partners, Dr. Strohmenger was involved in medical research with a primary focus on cardiovascular physiology and in research on health economics at the Ludwig-Maximilians-University in Munich, Germany. Dr. Strohmenger holds a Ph.D. in medicine as well as a M.Sc. in economics, both from Ludwig-Maximilians-University in Munich, Germany, and was trained at the Entrepreneurship Center of the MIT, Boston, USA. Dr. Strohmenger is a Member of the VC Council of the European Private Equity &Venture Capital Association (EVCA) and a Member of the Senate of the German Association for Small and Medium-sized Businesses (BVMW).
MODERATOR: Michel Govaert
Alvarez & Marsal Benelux
Michel Govaert is a Managing Director with Alvarez & Marsal practising more than 25 years international performance improvement and turnaround management. He is experienced in leading complex engagements working with supervisory boards, management teams, lenders and sponsors to quickly improve companies operational and financial performance. In the Private Equity Performance Improvement practice he has led numerous engagements developing and implementing value creation plans for portfolio companies with activities including development of new operating and business models, product- customer- and channel profitability analysis and improvement, cost reduction, margin improvement, working capital improvement, liquidity and cash management and building robust management control systems. He has led engagements across Asia Pacific, Latin America, Saudi Arabia, US and Europe, serving clients in a range of industries, including consumer goods, manufacturing, apparel, aviation, railway, automotive, real estate and agri-business. Mr. Govaert joined A&M in 2007, before he worked with Royal Philips Electronics in various CFO functions. He earned a master’s degree in business administration from Tilburg University in the Netherlands.
Mr Jeroen Regeur joined EQT Partners as Director in October 2013. Prior to joining EQT Partners Mr Regeur worked at Morgan Stanley Investment Banking, followed by seven years at TPG in London, most recently as Vice President at TPG Real Estate. Mr Regeur holds a B.Sc. and M.Sc. in Economics and Business from the Erasmus University in Rotterdam.
Abhishek Kapur (London) joined KKR Capstone in 2011. He has primarily been involved with KKR portfolio companies Avincis Group, Northgate, RigNet, and KKR's Special Situations investments, and leads KKR Capstone's Working Capital effort across KKR's European private equity portfolio. Prior to KKR Capstone he worked with The Boston Consulting Group in London focusing on infrastructure, transportation and industrial goods sectors. Mr. Kapur has previously been in various functional and general management roles within the A P Moller-Maersk Group in Singapore and Copenhagen. He holds an M.B.A., with distinction, from the London Business School and a B.Eng, with honors, from the National University of Singapore.
Wolfgang de Limburg
Ergon Capital Patners
Wolfgang de Limburg is Managing Partner of Ergon Capital Advisors, with responsibility over Northern Europe. He joined Ergon in early 2006 and is based in Brussels. He has 17 years of financial/private equity experience in Europe and the US and has invested in numerous sectors including pharma, healthcare, specialty chemicals, niche manufacturing, services and media. Wolfgang is currently a non executive director of Publihold/Groupe De Boeck, Larcier Holding, Elitech Group and Sausalitos Prior to joining Ergon, Wolfgang was CEO of Laboratoires Sterop Pharmacobel, a pharmaceutical company located in Belgium, which he joined in 2004. Before then, Wolfgang spent most of his career in investment banking at Lehman Brothers in New York and London, where he culminated as co-head of the European M&A Pharma team. He holds an MBA from the University of Chicago, Booth School of Business (US) and a Bachelor in Economics and Management from the Louvain School of Management (Belgium). Wolfgang is fluent in French, English and Dutch
Gilde Equity Management
Bas joined Gilde in 2004, having previously worked for Van Den Boom Groep Corporate Finance Consultants, where he held the position of M&A consultant. He joined the Financial Sponsors team at NIBCapital in 2000, and switched to the Principal Investments division in 2003, where he specialized in equity investments. Bas studied Business Management at the Free University and the Amsterdam Academy for Banking and Finance
Michel is a co-founder and Partner of Evoco Ltd and has over 12 years of experience as private equity investor. In his career to date, he has had exposure to most aspects of private equity investing: fund formation, deal origination, investment execution, and portfolio management / active ownership in the private equity industry and is a regular speaker at industry conventions or in academic institutions. Michel has been involved in investments in the natural resources, industrial, business services, healthcare, and media industries across Europe and emerging markets. Prior to Evoco, Michel was an Associate Director at HgCapital, working on a range of strategic and operational projects for portfolio companies. He began his career at UBS in the M&A Advisory Business and moved thereafter to 3i, where he was a member of the European buyout team. He has an MBA from IMD in Lausanne, Switzerland and a Master’s degree in Finance and Economics from the University of Berne, Switzerland. He has published about operational risk management and active ownership in the private equity industry. Michel speaks German, English and French.
Managing Director M&A Products
Bureau Van Dijk
Lisa has been working in the information industry for over twenty years and has a detailed knowledge of both company financial information and M&A data. She holds a post graduate qualification in Business and Management from Salford University and in 2013 also sat and passed the Certified Merger & Acquisition Advisor (CM&AA) certification programme in the US. Lisa Wright joined Zephus.com, a provider of M&A data, as Commercial Director in 2001 to manage the transition of its original business model from free to fee paying and to seek new revenue streams. Part of this transition was Lisa’s instigation of discussions with Bureau van Dijk (BvD), the leading publisher of global business information, regarding a co-published analytical M&A information product, Zephyr, which was successfully launched 2002. When the opportunity arose for BvD to acquire Zephus, Lisa participated in the sale process. Lisa is now BvD’s managing director for M&A products globally and oversees the research process for Zephyr. She is BvD’s product expert in Global M&A and acts in an advisory role to the group’s sales teams worldwide. Lisa writes a regular blog on BvD’s recently launched M&A Portal, providing an insight on current deals and emerging trends. Other written contributions include an article in “Mergers and Acquisitions – A Practical Guide for Private Companies and their UK and Overseas Advisors” published by Kogan Page Lisa is frequently asked to speak at international events on M&A trends both global and regionally.
Based in Amsterdam, Netherlands, Marc Staal joined AAC Capital in 2002. With his 19 years of experience in the private equity industry, he has been involved in all major transactions in the Benelux portfolio. He started his career at ABN AMRO and held several international positions in Corporate Finance and Equity Capital Markets. Marc holds a Masters in Economics from the University of Amsterdam.
Gijs Botman is the Managing Partner and Founder at Mentha Capital B.V., which he has co-founded in 2006. Prior to co-founding Mentha Capital, Gijs was a Partner in NeSBIC Special Partnerships Fund. Before that, he worked for Heineken. Gijs has over 12 years’ experience in private equity investments. Gijs holds an MSc in Economics and Business from the University of Amsterdam and is a Chartered Controller.
Vincent Braams joined the Vendis Capital Management as Partner in April 2015. Prior to joining the Vendis team, he had over 20 years of experience in the consumer sector, of which 17 years at established multinationals Nestlé and FrieslandCampina, and 4.5 years as CEO of private equity owned Smartwares (non-food consumer products), where he significantly grew the company through 11 buy-and-build transactions. Vincent holds an MBA from Erasmus University in Rotterdam and a Bachelor’s degree in Business Administration from the same university.
H2 Equity Partners
Harmen joined H2 in 2009. Prior to H2 he was Partner at Bain & Company where he advised CEO's of large and medium sized companies on strategy, performance improvement and organization. As a leader of Bain's private equity practice, he advised both corporates and private equity funds in M&A and commercial due diligence. Prior to Bain, Harmen worked at MeesPierson Corporate Finance & Capital Markets. He studied Econometrics at the Erasmus University Rotterdam. At H2 Harmen has led several acquisitions and subsequent restructuring and buy-and-build programs. At Sator – the automotive parts distributor – he supported management as non executive board member in the performance improvement program. Sator was divested successfully in May 2013 to LKQ Corporation. At Isero – the ironmongery distributor – he was responsible for the platform acquisition of Gerritse IJzerwaren and the subsequent buy-and-build program. At JET Group – the rooflight & ventilation manufacturer – he was responsible for the acquisition of the R&V companies from CRH and the subsequent post merger integration & growth program. At Reparenco – the paper mill and recovered paper trading business – he was responsible for the acquisition of Parenco and Reparco from Norske Skog and the subsequent turnaround and transformation. He is Chairman of the Supervisory Board of Parenco. Harmen's special interests include sports, investing and many other hobbies. Harmen is married to Leone and has three children Zaza, Fenne and Braz.
Caroline started her career in 1992 as an associate with the corporate finance & capital markets division of MeesPierson, where she worked closely together with Peter Visser and Jan Niessen. She was involved in a number of transactions. Furthermore, during 1994 and 1995, she was syndication manager of MeesPierson. For 15 months (end 1995 through 1996) Caroline worked for the structured finance division of ABN AMRO Bank in Johannesburg, South Africa. From 1997 to 2002 she worked with Van Lanschot Bankiers, where she headed the corporate office department. Caroline holds a Master's degree in Business Economics from the University of Groningen.
MODERATIOR: Eric Wijs
Managing Director & Head of Benelux
Eric is Head of the Benelux for Lincoln International and spearheads the business development and M&A activity in this region. Eric actively markets the firm’s services, manages client relationships and leads deal teams. Eric has more than 20 years of corporate finance experience in a broad range of industries across various geographies. Since 1993 he has advised clients on mergers, acquisitions, public take-overs, divestitures, capital raisings, public offerings, LBO’s, MBO’s, privatizations and restructurings. His clients include large public companies, privately held companies, private equity investors and government entities. Eric has advised clients on more than 50 completed transactions across a range of sectors including energy, financial services, consumer goods, retail, building & construction, building materials, healthcare, business services, transportation, infrastructure and media. Prior to joining Lincoln International to launch its Amsterdam office in 2010, Eric served 11 years with Lazard in its financial advisory practice. At Lazard, Eric was involved in setting up Lazard’s Amsterdam office in 2004 and as a managing director he was responsible for marketing Lazard’s services to clients in the Benelux and leading deal teams on a number of transactions. Before moving to Amsterdam Eric was based in Lazard’s offices in London (1998-2002) and Paris (2003) where he worked on assignments for Benelux and UK clients. Eric started his career with ING in Amsterdam in 1993 and, after the acquisition of Barings in 1995, he was seconded to the corporate finance unit of Baring Brothers & Co in London (1996-1998). At Barings he advised UK and Benelux clients on M&A and capital markets assignments. Eric graduated in Business Administration from the Erasmus University Rotterdam and holds a CEMS Master degree. Eric speaks Dutch, English, German and French.
Christiaan de Lint
Christiaan de Lint is a partner and co-founder of Headway Capital Partners, a London based firm which invests in private equity secondaries globally, with a focus on Europe and North America. Headway provides liquidity to institutions and individuals seeking an exit from their private equity investments, with a focus on portfolios of direct assets and structured transactions. Headway focuses on small to medium sized transactions. Prior to co-founding Headway in early 2004, Christiaan was part of the investment team at Coller Capital, one of the largest players in the private equity secondaries market where he worked since early 1999. Prior to Coller Capital, Christiaan worked in the Alternative Investment Strategies and Corporate Banking divisions of Citibank in London and New York. Christiaan received a BA in Economics and an MBA from the University of St. Gallen in Switzerland. Christiaan is Swiss-Dutch and is a CFA Charter-holder.
Before Charly joined Main at the beginning of 2003, he was a partner at AlpInvest Partners. He has also supervised the growth of an extensive portfolio of ICT participations. Charly has been a board member of over 20 technology companies. As managing partner, he currently holds board seats at SecondFloor, EuroSystems, Regas and Roxit. Charly studied Business Administration at the University of Groningen (RUG). Charly is married, lives in The Hague and has 5 children.
Pascal is a Partner of the firm. Previously, Pascal was a Senior Principal and Investment Committee member at Doughty Hanson, which he joined in 2003. Prior to Doughty Hanson, Pascal spent five years with PricewaterhouseCoopers working in its Transaction Services Department in Luxembourg and London. Pascal has a Bachelor of Science degree in Finance from HEC Management School - University of Liege and a MA degree in International Business Analysis from the University of Leicester
Forbion Capital Partners
Sander is Managing Partner of Forbion Capital Partners and co-founded ABN AMRO Capital Life Sciences in 2000 and Forbion Capital Partners in 2006. He currently serves on the boards of Forbion’s portfolio companies Replimune Ltd., Xention Discovery Ltd, Ario Pharma Ltd, Pulmagen Therapeutics, Ltd and Oxyrane Ltd. In addition, Sander was responsible for two of Forbion’s more recent exits: Dezima Pharma B.V. was sold to Amgen in September of 2015 for up to USD 1.55 billion plus royalties and Biovex, Inc. was sold to Amgen in March of 2011 for up to USD 1 billion. In recent years Sander has served on the boards of uniQure N.V. (QURE), Fovea Pharmaceutics S.A.(Sold to Sanofi in 2009), Argenta Discovery Ltd (sold to Galapagos in 2010), Alantos Pharmaceuticals, Inc. (sold to Amgen in 2007), Impella Cardiosystems AG (sold to Abiomed, Inc. in 2005), Glycart AG (sold to Roche in 2005), Pieris AG (PIRS) and has acted as the Chairman of the Board of AMT NV (Amsterdam, Netherlands / Euronext: AMT). Before co-founding Forbion Capital Partners, he was an Investment Director at ABN AMRO Capital Life Sciences. His other activities at ABN AMRO included buy-out/ growth equities at ABN AMRO Capital, Equity Capital Markets Syndications (HQ Amsterdam) and Financial Institutions Relationship Management Latin America (Regional Office Miami). Sander holds degrees in Business and Financial Economics from the Free University of Amsterdam and Business Administration from Nijenrode University, The Netherlands.
Theun van Halewijn
Partner-in-Charge, The Netherlands
Heidrick & Struggles
Theun van Halewijn is the partner in charge at Heidrick & Struggles’ Amsterdam office and a core team member of the firm’s global Semiconductor and Internet Practice, as well as of the European CFO Practice. Within the Heidrick global team, Theun focuses on technology and industry, and from a functional perspective on CEO, CFO and other finance roles. Theun has led more than 30 CEO and CFO assignments for companies owned by leading private equity firms. Prior to joining Heidrick & Struggles in 2006, Theun gained close to ten years’ experience in senior management positions with Royal Philips Electronics in France, Belgium and the Netherlands. In his last function, he was responsible for the product planning of the Philips LCD TV business globally, in a period of tremendous growth. Prior to that, Theun spent three years in Philips Corporate Strategy, working closely with the board and the CEO of Philips, and before that he worked in Philips’ Car Systems division. Theun spent the first three years of his career in Aerospace, working for Fokker Aircraft and Daimler Benz Aerospace (Dornier) in Munich. Theun holds a master’s degree from Delft University of Technology and an MBA from INSEAD. He is fluent in English, French, German and Dutch.
"As Raet's CFO, I’m committed to ensuring the sustainable growth of our organization. I strongly believe in innovation as a driver of growth. For example, as consumers, we now find it perfectly normal to manage our affairs via cloud services from anywhere and at any time. This especially holds true for younger generations who are used to sharing information via the cloud at lightning speeds. This is the new reality. Raet enables this new reality for HR services. This calls for continuous investments, not only in terms of technology, innovation and efficiency, but also in terms of people. This is how we make a difference for our customers and for the 1.7 million employees who use our software on a daily basis."
Marc Zwaaneveld is CEO of Van Gansewinkel Groep since January 2015. He joined Van Gansewinkel in 2014 as COO and brings a broad experience in the Waste Management and Recycling sector. Prior to Van Gansewinkel he was Vice-Chairman and CFO at SITA Benelux & Germany (2005-2011), partner at consultancy firm Accenture and held various positions at DAF Trucks.
Bart Devos is CEO of AR Metallizing, the leading global provider of specialty technical coatings for metallized applications. Bart’s key expertise is change management of internationally operating groups and help stakeholders (e.g. investment companies, private investors) accomplish business goals (e.g. regarding growth, revenue, investments, change of business and/or revenue model) in an optimal way. Prior to joining AR Metallizing in 2013, Bart has held various chief executive positions, most notably as CEO or CFO, for internationally operating groups headquartered in Europe. Work highlights include: 1) The sale of AR Metallizing to Japan-based multinational Nissha Printing backed by the British private equity investment group HIG Capital (2015). 2) Change management of AR Metallizing resulting in a shift of 2 mio € EBITDA into 14.6 mio € EBITDA in less than 1 year time (2014). 3) Complete change management at Brainwash Hairdressers resulting in a shift of negative EBITDA of 800k € into a positive EBITDA of 2.5 mio € in a period of 1 year time (2011-2012). 4) Complete change management at Nebus Loyalty resulting in a shift of a negative EBITDA of 3 mio € into a positive EBITDA of 10 mio € EBITDA in less than two years time (2009-2011). Dr. Devos holds masters in applied economics, marketing and finance (Sint-Aloysius Brussels, Belgium), as well as a graduate degree in international trade, M.B.A. (Magna cum Laude) and Ph.D. (Magna cum Laude) degrees from the Solvay School of Business (Université Libre de Bruxelles, Belgium).
Ad Van Geloven
1974-1980 Doctoraal Pharmacie 1980-1983 Alza (Projectleader) 1983-1985 MBA Stanford Business School 1985-1989 Gist Brocades (President France and US) 1989-1993 World Software Group (Vice President) 1993-2007 Sara Lee (Manager M&A, President Household & bodycare Germany & Austria, President Sara Lee Food) 2007-2009 MeadWestVaco (President Europe) 2009-nu Van Geloven (CEO)